Improving quality of care and clinical outcomes for rectal cancer through clinical audits in a multicentre cancer care organisation

被引:2
作者
Torras, M. G. [1 ]
Canals, E. [2 ]
Munoz-Montplet, C. [3 ]
Vidal, A. [4 ]
Jurado, D. [3 ]
Eraso, A. [2 ]
Villa, S. [5 ]
Caro, M. [5 ]
Molero, J. [3 ]
Macia, M. [6 ]
Puigdemont, M. [7 ]
Gonzalez-Munoz, E. [4 ]
Lopez, A. [8 ]
Guedea, F. [6 ]
Borras, J. M. [9 ]
机构
[1] Inst Catala Oncol, Clin Management Dept, Barcelona, Spain
[2] Inst Catala Oncol, Dept Radiat Oncol, Girona, Spain
[3] Inst Catala Oncol, Med Phys & Radiat Protect Dept, Girona, Spain
[4] Inst Catala Oncol, Qual & Results Dept, Girona, Spain
[5] Inst Catala Oncol, Dept Radiat Oncol, Badalona, Spain
[6] Inst Catala Oncol, Dept Radiat Oncol, Barcelona, Spain
[7] Inst Catala Oncol, Hosp Tumor Registry, Girona, Spain
[8] Inst Catala Oncol, Canc Prevent & Control Program, Barcelona, Spain
[9] Univ Barcelona, Dept Clin Sci, IDIBELL, Barcelona, Spain
关键词
Rectal Cancer; Clinical audit; Radiotherapy process; Clinical practice variability; Improvement Quality process; PREOPERATIVE RADIOTHERAPY; MESORECTAL EXCISION; CHEMORADIATION; CENTRALIZATION; RECURRENCE; MANAGEMENT; PATTERNS; SURGERY; WATCH;
D O I
10.1186/s13014-020-1465-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Colorectal cancer treatment requires a complex, multidisciplinary approach. Because of the potential variability, monitoring through clinical audits is advisable. This study assesses the effects of a quality improvement action plan in patients with locally advanced rectal cancer and treated with radiotherapy. Methods Comparative, multicentre study in two cohorts of 120 patients each, selected randomly from patients diagnosed with rectal cancer who had initiated radiotherapy with a curative intent. Based on the results from a baseline clinical audit in 2013, a quality improvement action plan was designed and implemented; a second audit in 2017 evaluated its impact. Results Standardised information was present on 77.5% of the magnetic resonance imaging (MRI) staging reports. Treatment strategies were similar in all three study centres. Of the patients whose treatment was interrupted, just 9.7% received a compensation dose. There was an increase in MRI re-staging from 32.5 to 61.5%, and a significant decrease in unreported circumferential resection margins following neoadjuvant therapy (ypCRM), from 34.5 to 5.6% (p < 0.001). Conclusions The comparison between two clinical audits showed improvements in neoadjuvant radiotherapy in rectal cancer patients. Some indicators reveal areas in need of additional efforts, for example to reduce the overall treatment time.
引用
收藏
页数:9
相关论文
共 30 条
  • [1] Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation
    Bese, Nuran Senel
    Hendry, Jolyon
    Jeremic, Branislav
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (03): : 654 - 661
  • [2] Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study
    Brown, G.
    Daniels, I. R.
    Heald, R. J.
    Quirke, P.
    Blomqvist, L.
    Sebag-Montefiore, D.
    Moran, B. J.
    Holm, T.
    Strassbourg, J.
    Peppercorn, P. D.
    Fisher, S. E.
    Mason, B.
    [J]. BRITISH MEDICAL JOURNAL, 2006, 333 (7572): : 779 - 782
  • [3] Long-course oxaliplatin-based preoperative chemoradiation versus 5 x 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study
    Bujko, K.
    Wyrwicz, L.
    Rutkowski, A.
    Malinowska, M.
    Pietrzak, L.
    Krynski, J.
    Michalski, W.
    Oledzki, J.
    Kusnierz, J.
    Zajac, L.
    Bednarczyk, M.
    Szczepkowski, M.
    Tarnowski, W.
    Kosakowska, E.
    Zwolinski, J.
    Winiarek, M.
    Wisniowska, K.
    Partycki, M.
    Beczkowska, K.
    Polkowski, W.
    Stylinski, R.
    Wierzbicki, R.
    Bury, P.
    Jankiewicz, M.
    Paprota, K.
    Lewicka, M.
    Cisel, B.
    Skorzewska, M.
    Mielko, J.
    Bebenek, M.
    Maciejczyk, A.
    Kapturkiewicz, B.
    Dybko, A.
    Hajac, L.
    Wojnar, A.
    Lesniak, T.
    Zygulska, J.
    Jantner, D.
    Chudyba, E.
    Zegarski, W.
    Las-Jankowska, M.
    Jankowski, M.
    Kolodziejski, L.
    Radkowski, A.
    Zelazowska-Omiotek, U.
    Czeremszynska, B.
    Kepka, L.
    Kolb-Sielecki, J.
    Toczko, Z.
    Fedorowicz, Z.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 (05) : 834 - 842
  • [4] A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis
    Dossa, Fahima
    Chesney, Tyler R.
    Acuna, Sergio A.
    Baxter, Nancy N.
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (07): : 501 - 513
  • [5] Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
    Ferlay, J.
    Steliarova-Foucher, E.
    Lortet-Tieulent, J.
    Rosso, S.
    Coebergh, J. W. W.
    Comber, H.
    Forman, D.
    Bray, F.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) : 1374 - 1403
  • [6] Preoperative radiotherapy for rectal cancer: a comparative study of quality control adherence at two cancer hospitals in Spain and Poland
    Fundowicz, Magdalena
    Macia, Miguel
    Marin, Susanna
    Bogusz-Czerniewicz, Marta
    Konstanty, Ewelina
    Modolel, Ignaci
    Malicki, Julian
    Guedea, Ferran
    [J]. RADIOLOGY AND ONCOLOGY, 2014, 48 (02) : 210 - 218
  • [7] Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer
    Kapiteijn, E
    Marijnen, CAM
    Nagtegaal, ID
    Putter, H
    Steup, WH
    Wiggers, T
    Rutten, HJT
    Pahlman, L
    Glimelius, B
    van Krieken, JHJM
    Leer, JWH
    van de Velde, CJH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (09) : 638 - 646
  • [8] Multidisciplinary Management of Locally Advanced Rectal Cancer-An Evolving Landscape?
    Lee, Margaret
    Gibbs, Peter
    Wong, Rachel
    [J]. CLINICAL COLORECTAL CANCER, 2015, 14 (04) : 251 - 261
  • [9] MESORECTAL EXCISION FOR RECTAL-CANCER
    MACFARLANE, JK
    RYALL, RDH
    HEALD, RJ
    [J]. LANCET, 1993, 341 (8843) : 457 - 460
  • [10] Improving survival and local control in rectal cancer in Catalonia (Spain) in the context of centralisation: A full cycle audit assessment
    Manchon-Walsh, P.
    Aliste, L.
    Espinas, J. A.
    Prades, J.
    Guarga, A.
    Balart, J.
    Biondo, S.
    Castells, A.
    Sanjuan, X.
    Tabernero, J.
    Borras, J. M.
    [J]. EJSO, 2016, 42 (12): : 1873 - 1880